2022. LHX1 as a potential biomarker regulates EMT induction and cellular behaviors in uterine corpus endometrial carcinoma. Clinics. 77, (Sep. 2022), 100103. DOI:https://doi.org/10.1016/j.clinsp.2022.100103.